Successful treatment of isohemagglutinin-mediated pure red cell aplasia after ABO-mismatched allogeneic hematopoietic cell transplant using bortezomib

Bone Marrow Transplantation

Volumn 47, Issue 6, 2012, Pages 870-871

  Poon, L M ^a   Koh, L P ^a  

^a Cancer Institute   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; BUSULFAN; CYCLOPHOSPHAMIDE; HEMAGGLUTININ; IMMUNOGLOBULIN G; ISOHEMAGGLUTININ; METHOTREXATE; RITUXIMAB; TACROLIMUS; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CANCER RISK; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DONOR LYMPHOCYTE INFUSION; DRUG RESPONSE; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN TISSUE; LETTER; MALE; MANTLE CELL LYMPHOMA; MEDICAL HISTORY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTE COUNT; RISK ASSESSMENT; TREATMENT PLANNING;

ABO BLOOD-GROUP SYSTEM; ADULT; ANTINEOPLASTIC AGENTS; BORONIC ACIDS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; PYRAZINES; RED-CELL APLASIA, PURE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84862222467     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2011.176     Document Type: Letter

References (7)

1. O'Donnell MR. Blood group Incompatibilities and hemolytic complications of hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG (eds). Thomas' Hematopoietic Cell Transplantation, 4th edn, Wiley-Blackwell: Chichester, West Sussex, UK, 2008, pp 1219-1225.
2. Mielcarek M, Leisenring W, Torok-Storb B, Storb R. Graftversus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: Evidence for a graft-versus-plasma cell effect. Blood 2000; 96: 1150-1156.
3. Gmur JP, Burger J, Schaffner A, Neftel K, Oelz O, Frey D et al. Pure red cell aplasia of long duration complicating major ABOincompatible bone marrow transplantation. Blood 1990; 75: 290-295.
4. Fang B, Song Y, Li N, Li J, Han Q, Zhao RC. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Ann Hematol 2009; 88: 261-266.
5. Raab MS, Podar K, Breitkreutz I, Richardson PG, Anderson KC. Multiple myeloma. Lancet 2009; 374: 324-339.
6. Kane RC, Dagher R, Farrell A, Ko CW, Sridhara R, Justice R et al. Bortezomib for the treatment of mantle cell lymphoma. Clin Cancer Res 2007; 13: 5291-5294.
7. Carson KR, Beckwith LG, Mehta J. Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib. Blood 2010; 115: 915.